Scientific American: How Eli Lilly's New GLP-1 Pill Foundayo Stacks Up Against Wegovy
In-depth comparison of Foundayo against existing GLP-1 drugs, noting 27 lbs average weight loss over 72 weeks at the highest dose. Experts hope more oral options will drive down costs and offer patients greater flexibility versus injectable regimens.